Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pasifolate Exatecan
Ovarian Adenocarcinoma
Elucida Oncology
P1/2
CC
(45)
Patient Derived Cd19 Specific Car T Cells Also Expressing An Egfrt
Acute Leukemia
Seattle Children's Hospital
P1/2
CC
(45)
PBR-06
Multiple Sclerosis
Brigham and Women's Hospital
P1/2
CC
(45)
pds01adc
Penile Cancer
National Cancer Institute (NCI)
P1/2
CC
(45)
Pedmark® Sts
Testicular Cancer
University of Arizona
P1/2
CC
(45)
Pedmark® Sts
Thoracic Cancer
University of Arizona
P1/2
CC
(45)
Penpulimab
Malignant Pancreatic Neoplasm
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1/2
CC
(45)
Penpulimab
Cancer
Akeso
P1/2
CC
(45)
Pentoxifylline
Cognitive Disorder
The First Hospital of Hebei Medical University
P1/2
CC
(45)
Pep-Dc1
Ovarian Carcinoma
Centre Hospitalier Universitaire Vaudois
P1/2
CC
(45)
Pep-Dc2
Ovarian Carcinoma
Centre Hospitalier Universitaire Vaudois
P1/2
CC
(45)
Pertzye
Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
Pertzye
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(45)
Petiveria Alliacea Preparation
Pancreatic Neoplasm
Hospital Universitario San Ignacio
P1/2
CC
(45)
Pevonedistat
Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(45)
Phase 1, Sqy51
Duchenne Muscular Dystrophy
Sqy Therapeutics
P1/2
CC
(45)
plx2853
Uveal Melanoma
Alliance for Clinical Trials in Oncology
P1/2
CC
(45)
pm1009
Hepatocellular Carcinoma
Biotheus Inc.
P1/2
CC
(45)
Pocenbrodib
Castration-Resistant Prostate Carcinoma
Pathos AI, Inc.
P1/2
CC
(45)
Polatuzumab Vedotin
Burkitt Lymphoma
New York Medical College
P1/2
CC
(45)
prg2505
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Primepro™/ Primemsk™
Autoimmune Disease
Thomas Advanced Medical LLC
P1/2
CC
(45)
prj1-3024
Cancer
Zhuhai Yufan Biotechnologies Co., Ltd
P1/2
CC
(45)
Ptx-9908
Hepatocellular Carcinoma
TCM Biotech International Corp.
P1/2
CC
(45)
Pumitamig
Head And Neck Squamous Cell Carcinoma
Bristol-Myers Squibb
P1/2
CC
(45)
Showing 3751 to 3775 of 6,299 assets
Previous
Page 151 of 252
Next